Home › Conditions › Hyperkalaemia
Renal
Hyperkalaemia
Serum potassium · mmol/L
Hyperkalaemia: K+ ≥5.5 mmol/L. K+ ≥6.5 or toxic ECG changes: emergency treatment. At K+ ≥6.0, obtain an urgent ECG. Possible ECG changes: peaked T waves → PR prolongation → P wave loss → broad QRS → sine wave → VF/asystole; they may not follow this sequence. A normal ECG does not exclude danger.
Hyperkalaemia Management Protocol
The pathway
ECG immediately
- Peaked T waves
- PR prolongation
- Wide QRS
- Sine wave pattern
- Any ECG changes = treat urgently regardless of K+ level.
Stabilise the membrane
- Calcium gluconate 10% 30ml IV over 10 minutes — 6.8mmol calcium (UKKA 2023)
- In arrest or peri-arrest: calcium chloride 10% 10ml over 5 minutes is the preferred salt
- Protects the heart
- Does NOT lower K+
- Effect within 3 minutes, lasts 30–60 minutes
- Repeat if ECG changes persist.
Shift K+ into cells
- Insulin 10 units in 25g glucose IV — 50ml of 50% or 250ml of 10%
- If pre-treatment BM <7.0, follow with 10% glucose 50ml/hr for 5 hours
- BM at 0, 30, 60, 90 and 120 minutes, then hourly to 6 hours — hourly checks miss early hypoglycaemia
- Lowers K+ by 0.5–1.5 mmol/L
Salbutamol nebuliser
- 10–20mg nebulised
- Additive to insulin-dextrose
- Lowers K+ by 0.5–1 mmol/L
- Caution in ischaemic heart disease.
Remove K+ from body
- Sodium zirconium cyclosilicate (SZC) or patiromer — the novel binders, now recommended for moderate and severe hyperkalaemia. SZC may also be started in primary care to support RAASi optimisation
- Calcium resonium has been REMOVED from the emergency hospital algorithm (UKKA 2023). It is no longer recommended for chronic hyperkalaemia either (UKKA July 2026)
- Consider dialysis in AKI with refractory hyperkalaemia
- Binders act over hours — they do not replace calcium and insulin-dextrose in an emergency
Treat cause
Stop potassium supplements, potassium-sparing diuretics, ACEi/ARB, NSAIDs. Treat AKI, acidosis, rhabdomyolysis.
Monitor
After treating moderate/severe hyperkalaemia, repeat K+ at least at 1, 2, 4, 6 and 24 hours. Continuous cardiac monitoring until K+ <5.5 and no ECG changes.
Drugs
| Drug | Dose | Route | Notes |
|---|---|---|---|
| Calcium gluconate 10% | 30ml | IV | Over 10 minutes — 6.8mmol calcium. Membrane stabilisation. Calcium chloride 10% 10ml over 5 min is the preferred salt in arrest. Repeat if ECG changes persist. |
| Actrapid insulin | 10 units | IV | In 25g glucose — 50ml of 50% or 250ml of 10%. BM at 0, 30, 60, 90 and 120 minutes, then hourly to 6 hours. If pre-treatment BM <7.0, follow with 10% glucose 50ml/hr for 5 hours (UKKA 2026). |
| Salbutamol | 10–20mg | Nebulised | Additive to insulin/glucose, not monotherapy. Ischaemic heart disease: consider 10 mg with cardiac monitoring; watch for tachyarrhythmia. |
| Sodium zirconium cyclosilicate | 10g TDS (up to 72h), then 5g OD | Oral | Potassium binder. Replaced calcium resonium in the UKKA 2023 emergency algorithm. May also be started in primary care to support RAASi optimisation (UKKA July 2026). Onset ~1h — an adjunct, never a substitute for calcium and insulin-dextrose. |
| Patiromer | 8.4g OD | Oral | Alternative binder; slower onset than SZC — not a replacement for emergency calcium/insulin–glucose. Review ongoing need after the acute episode. |
| Sodium bicarbonate 8.4% | 50ml | IV | Not routine for acute hyperkalaemia (UKKA 2026). Only where severe acidosis is being treated in its own right, on senior advice. |
When to escalate
- K+ ≥6.5 mmol/L, or ECG changes suggesting hyperkalaemia — emergency; a normal ECG does not make severe hyperkalaemia safe
- VT/VF — ALS
- AKI not responding to treatment — dialysis
- K+ not falling after two cycles of treatment
Reference: UK Kidney Association — Treatment of Acute Hyperkalaemia in Adults 2023
Practise and explore
Practise a case or explore differentials here on the website. The optional browser app adds personal learning tools and saved progress.